Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

SDZ-266806: A novel squalene synthase inhibitor

Aug. 30, 1996

Estrogenic compounds from Sankyo

Aug. 30, 1996

Prophylactic tibolone shown effective in 2 year study

Aug. 30, 1996

Columbia Laboratories granted U.S. patent for Crinone technology

Aug. 23, 1996

Astra's Atmos launched in Sweden

Aug. 23, 1996

Humatrope approved for new indication in U.S.

Aug. 23, 1996

Update on Biotech Holdings' Diab II

Aug. 23, 1996

Alteon initiates phase III trials of pimagedine

Aug. 23, 1996

Johnson & Johnson continues pramlintide collaboration

Aug. 23, 1996

Pramlintide shows positive safety/efficacy profile in phase II

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...